The AHA July 20 submitted comments on proposed Centers for Medicare & Medicaid Services regulations that would support state flexibility in Medicaid drug value-based purchasing arrangements and other changes to the Medicaid drug rebate program for fiscal year 2021.

“The AHA supports innovations in drug purchasing arrangements, so long as these arrangements preserve or enhance patient access to critical medications and result in lower drug costs,” AHA wrote. “As CMS continues to pursue an increase in VBP opportunity, we urge the agency to consider the appropriate balance that must be struck to make these arrangements work effectively for the Medicaid program as well as throughout the health care delivery system.”

AHA also urged the agency to extend the comment period beyond the current 30-day period to allow stakeholders’ thoughtful and careful consideration for assessing the implications of applying VBP arrangements for Medicaid drug coverage and purchasing.

Related News Articles

Headline
As the Congressional Telehealth Caucus considers updates to legislation that would permanently remove all geographic restrictions on Medicare telehealth…
Headline
The Centers for Medicare & Medicaid Services Friday released additional guidance on changes to the Medicaid continuous enrollment requirement under…
Headline
The Centers for Medicare & Medicaid Services yesterday approved the first Medicaid demonstration to provide a limited set of health care services to…
Blog
According to the CDC, 80% of pregnancy-related deaths can be prevented; that’s a 20% increase from previous years. Know why? That’s actually the theme for…
Headline
The recently enacted Consolidated Appropriations Act delays by one year, until Jan. 1, 2024, payment reductions of up to 15% under the Medicare Clinical…
Headline
States that expanded Medicaid coverage to low-income adults in 2014 under the Affordable Care Act reduced postpartum hospitalizations for low-income people,…